CCEL
Cryo-Cell International, Inc.
Price Chart
Latest Quote
$4.05
+0.52 (+14.73%)
Current Price
| Previous Close | $3.53 |
| Open | $3.49 |
| Day High | $4.05 |
| Day Low | $3.46 |
| Volume | 6,792 |
Stock Information
| Shares Outstanding | 8.06M |
| Total Debt | $10.71M |
| Cash Equivalents | $2.90M |
| Revenue | $31.28M |
| Net Income | $-2.67M |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Market Cap | $32.62M |
| EPS (TTM) | $-0.32 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $35.60M |
| Sales | $31.28M |
| Income | $-2.67M |
| Book/sh | $-2.28 |
| Cash/sh | $0.36 |
| Employees | 72 |
Financial Ratios
| Quick Ratio | 0.55 |
| Current Ratio | 0.62 |
| EPS Growth TTM | -83.30% |
Returns & Margins
| ROA | 0.19% |
| Gross Margin | 63.53% |
| Operating Margin | 9.96% |
| Profit Margin | -8.52% |
Ownership
| Insider Ownership | 42.07% |
| Institutional Ownership | 11.96% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 202.50 |
| PEG | 1.34 |
| P/S | 1.04 |
| P/B | -1.77 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $3.53 |
| SMA50 | $3.56 |
| SMA200 | $3.79 |
| RSI | 68.09 |
| ATR | 0.2171 |
| Shares Float | 4.17M |
| Short Float | 0.28% |
| Short Ratio | 1.69 |
| Volatility | 0.57 |
| Rel Volume | 2.27 |
Performance History
| Week | nan% |
| Month | nan% |
| Quarter | nan% |
| 6 Months | nan% |
| YTD | nan% |
| Year | nan% |
| 3 Years | nan% |
| 5 Years | nan% |
| 10 Years | nan% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $4.05 | 14,200 |
| 2026-06-17 | $3.53 | 1,100 |
| 2026-06-16 | $3.45 | 1,600 |
| 2026-06-15 | $3.60 | 3,600 |
| 2026-06-12 | $3.56 | 1,800 |
| 2026-06-11 | $3.63 | 9,000 |
| 2026-06-10 | $3.63 | 3,700 |
| 2026-06-09 | $3.45 | 2,300 |
| 2026-06-08 | $3.67 | 4,500 |
| 2026-06-05 | $3.50 | 0 |
| 2026-06-04 | $3.50 | 4,200 |
| 2026-06-03 | $3.45 | 2,100 |
| 2026-06-02 | $3.39 | 2,000 |
| 2026-06-01 | $3.55 | 3,800 |
| 2026-05-29 | $3.37 | 8,200 |
| 2026-05-28 | $3.62 | 15,800 |
| 2026-05-27 | $3.39 | 19,400 |
| 2026-05-26 | $3.40 | 20,800 |
| 2026-05-22 | $3.46 | 1,600 |
| 2026-05-21 | $3.44 | 5,300 |
| 2026-05-20 | $3.49 | 5,600 |
| 2026-05-19 | $3.51 | 2,000 |
About Cryo-Cell International, Inc.
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
đ° Latest News
No news articles available at the moment. Check back later for updates on CCEL.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,760,004 | $7,409,677 | $7,804,280 | $8,102,544 |
| Cost Of Revenue | $7,376,648 | $7,947,752 | $8,390,463 | $8,792,358 |
| Total Revenue | $31,566,321 | $31,986,106 | $31,343,695 | $30,336,749 |
| Operating Revenue | $31,566,321 | $31,986,106 | $31,343,695 | $30,336,749 |
| Expenses | ||||
| Interest Expense | $2,066,256 | $1,864,684 | $1,236,794 | $1,521,767 |
| Total Expenses | $26,725,093 | $28,197,822 | $27,853,508 | $25,876,949 |
| Other Income Expense | $-5,112,125 | $880,521 | $-15,617,888 | $380,915 |
| Other Non Operating Income Expenses | $52,976 | $6,583 | $3,441 | $1,676 |
| Net Non Operating Interest Income Expense | $-2,066,256 | $-1,864,684 | $-1,236,794 | $-1,521,767 |
| Interest Expense Non Operating | $2,066,256 | $1,864,684 | $1,236,794 | $1,521,767 |
| Operating Expense | $19,348,445 | $20,250,070 | $19,463,045 | $17,084,591 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Net Interest Income | $-2,066,256 | $-1,864,684 | $-1,236,794 | $-1,521,767 |
| Normalized Income | $1,651,045 | $-288,316 | $1,608,528 | $2,454,743 |
| Net Income From Continuing And Discontinued Operation | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Total Operating Income As Reported | $482,394 | $3,480,284 | $-12,304,032 | $4,024,467 |
| Net Income Common Stockholders | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Net Income | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Net Income Continuous Operations | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Pretax Income | $-2,337,153 | $2,804,121 | $-13,364,495 | $3,318,948 |
| Special Income Charges | $-4,358,834 | $-308,000 | $-15,794,219 | $-27,989 |
| Operating Income | $4,841,228 | $3,788,284 | $3,490,187 | $4,459,800 |
| Depreciation Amortization Depletion Income Statement | $751,474 | $483,522 | $1,124,228 | $1,119,528 |
| Depreciation And Amortization In Income Statement | $751,474 | $483,522 | $1,124,228 | $1,119,528 |
| Gross Profit | $24,189,673 | $24,038,354 | $22,953,232 | $21,544,391 |
| Per Share | ||||
| Diluted EPS | $-0.30 | $0.05 | $-1.15 | $0.33 |
| Basic EPS | $-0.30 | $0.05 | $-1.15 | $0.33 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,084,671 | $183,527 | $-4,491,132 | $62,574 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $6,262,322 | $4,816,464 | $5,204,039 | $6,270,818 |
| Total Unusual Items | $-5,165,101 | $873,938 | $-15,621,329 | $379,239 |
| Total Unusual Items Excluding Goodwill | $-5,165,101 | $873,938 | $-15,621,329 | $379,239 |
| Reconciled Depreciation | $1,368,118 | $1,021,597 | $1,710,411 | $1,809,342 |
| EBITDA (Bullshit earnings) | $1,097,221 | $5,690,402 | $-10,417,290 | $6,650,057 |
| EBIT | $-270,897 | $4,668,805 | $-12,127,701 | $4,840,715 |
| Diluted Average Shares | $8,068,777 | $8,212,510 | $8,286,785 | $8,483,994 |
| Basic Average Shares | $8,068,777 | $8,130,676 | $8,286,785 | $8,465,568 |
| Diluted NI Availto Com Stockholders | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Tax Provision | $92,232 | $2,402,026 | $-3,842,826 | $547,540 |
| Write Off | $4,358,834 | $308,000 | $3,737,133 | $0 |
| Gain On Sale Of Security | $-806,267 | $1,181,938 | $172,890 | $407,228 |
| Research And Development | $376,263 | $1,242,536 | $1,171,456 | $384,789 |
| Selling General And Administration | $18,220,708 | $18,524,012 | $17,167,361 | $15,580,274 |
| Impairment Of Capital Assets | - | $0 | $13,108,064 | $0 |
| Restructuring And Mergern Acquisition | - | $2,794 | $-1,050,978 | $435,333 |
| Gain On Sale Of Ppe | - | - | $0 | $407,344 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-21,410,414 | $-16,078,682 | $-13,961,764 | $-18,620,053 |
| Total Assets | $61,728,514 | $64,677,633 | $61,220,770 | $64,888,054 |
| Total Non Current Assets | $49,970,293 | $52,123,040 | $51,767,933 | $55,277,869 |
| Other Non Current Assets | $1,691,099 | $5,757,750 | $6,006,612 | $9,922,570 |
| Non Current Deferred Assets | $23,620,711 | $20,802,023 | $20,492,749 | $13,742,399 |
| Non Current Deferred Taxes Assets | $23,620,711 | $20,802,023 | $20,492,749 | $13,742,399 |
| Goodwill And Other Intangible Assets | $2,804,485 | $2,862,665 | $2,930,532 | $17,095,751 |
| Other Intangible Assets | $863,074 | $921,254 | $989,121 | $15,154,340 |
| Current Assets | $11,758,221 | $12,554,593 | $9,452,837 | $9,610,185 |
| Other Current Assets | $633,985 | $454,598 | $389,950 | $426,879 |
| Prepaid Assets | $573,218 | $637,055 | $615,407 | $566,557 |
| Inventory | $408,794 | $657,703 | $768,877 | $851,230 |
| Receivables | $6,846,180 | $7,309,094 | $6,576,240 | $6,043,941 |
| Accounts Receivable | $6,846,180 | $7,309,094 | $6,576,240 | $6,043,941 |
| Allowance For Doubtful Accounts Receivable | $-4,306,410 | $-4,266,405 | $-3,822,300 | $-3,528,119 |
| Gross Accounts Receivable | $11,152,590 | $11,575,499 | $10,398,540 | $9,572,060 |
| Cash Cash Equivalents And Short Term Investments | $3,296,044 | $3,496,143 | $980,250 | $1,721,578 |
| Cash And Cash Equivalents | $319,031 | $560,960 | $406,067 | $1,703,958 |
| Investmentin Financial Assets | - | $0 | $308,000 | $308,000 |
| Hedging Assets Current | - | $0 | $122,113 | $0 |
| Non Current Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $10,334,749 | $11,439,573 | $9,412,339 | $9,299,172 |
| Total Debt | $11,558,629 | $12,933,920 | $10,896,030 | $11,614,119 |
| Long Term Debt And Capital Lease Obligation | $8,644,758 | $8,815,098 | $9,281,975 | $8,893,173 |
| Long Term Debt | $8,170,130 | $8,310,045 | $8,430,037 | $8,579,875 |
| Current Debt And Capital Lease Obligation | $2,913,871 | $4,118,822 | $1,614,055 | $2,720,946 |
| Current Debt | $2,483,650 | $3,690,488 | $1,388,369 | $2,423,255 |
| Other Current Borrowings | $183,650 | $170,488 | $165,641 | $150,527 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $80,334,443 | $77,893,650 | $72,252,002 | $66,412,356 |
| Total Non Current Liabilities Net Minority Interest | $60,541,456 | $56,294,108 | $51,388,001 | $46,930,936 |
| Other Non Current Liabilities | $922,020 | $922,020 | $919,226 | $2,037,704 |
| Non Current Deferred Liabilities | $50,974,678 | $46,556,990 | $41,186,800 | $36,000,059 |
| Current Liabilities | $19,792,987 | $21,599,542 | $20,864,001 | $19,481,420 |
| Current Deferred Liabilities | $9,730,318 | $9,788,574 | $9,704,553 | $9,586,327 |
| Payables And Accrued Expenses | $7,148,798 | $7,692,146 | $8,345,393 | $5,191,111 |
| Interest Payable | $1,389,384 | $1,382,068 | $1,111,853 | $1,038,799 |
| Payables | $2,870,771 | $3,303,058 | $4,601,061 | $1,947,407 |
| Total Tax Payable | $0 | $1,420,784 | $1,426,477 | $342,106 |
| Accounts Payable | $2,870,771 | $1,882,274 | $3,174,584 | $1,605,301 |
| Equity | ||||
| Common Stock Equity | $-18,605,929 | $-13,216,017 | $-11,031,232 | $-1,524,302 |
| Total Equity Gross Minority Interest | $-18,605,929 | $-13,216,017 | $-11,031,232 | $-1,524,302 |
| Stockholders Equity | $-18,605,929 | $-13,216,017 | $-11,031,232 | $-1,524,302 |
| Retained Earnings | $-38,438,238 | $-32,777,626 | $-31,159,182 | $-21,637,513 |
| Other | ||||
| Treasury Shares Number | $6,821,969 | $6,787,460 | $6,562,461 | $6,347,490 |
| Ordinary Shares Number | $8,055,150 | $8,082,159 | $8,286,785 | $8,500,511 |
| Share Issued | $14,877,119 | $14,869,619 | $14,849,246 | $14,848,001 |
| Tangible Book Value | $-21,410,414 | $-16,078,682 | $-13,961,764 | $-18,620,053 |
| Invested Capital | $-7,952,149 | $-1,215,484 | $-1,212,826 | $9,478,828 |
| Working Capital | $-8,034,766 | $-9,044,949 | $-11,411,164 | $-9,871,235 |
| Capital Lease Obligations | $904,849 | $933,387 | $1,077,624 | $610,989 |
| Total Capitalization | $-10,435,799 | $-4,905,972 | $-2,601,195 | $7,055,573 |
| Treasury Stock | $25,025,058 | $24,855,556 | $23,431,685 | $22,632,649 |
| Additional Paid In Capital | $44,708,596 | $44,268,469 | $43,411,143 | $42,597,380 |
| Capital Stock | $148,771 | $148,696 | $148,492 | $148,480 |
| Common Stock | $148,771 | $148,696 | $148,492 | $148,480 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Deferred Revenue | $50,974,678 | $46,556,990 | $41,186,800 | $36,000,059 |
| Long Term Capital Lease Obligation | $474,628 | $505,053 | $851,938 | $313,298 |
| Current Deferred Revenue | $9,730,318 | $9,788,574 | $9,704,553 | $9,586,327 |
| Current Capital Lease Obligation | $430,221 | $428,334 | $225,686 | $297,691 |
| Line Of Credit | $2,300,000 | $3,520,000 | $1,222,728 | $2,272,728 |
| Current Accrued Expenses | $4,278,027 | $4,389,088 | $3,744,332 | $3,243,704 |
| Goodwill | $1,941,411 | $1,941,411 | $1,941,411 | $1,941,411 |
| Net PPE | $21,853,998 | $22,700,602 | $22,030,040 | $14,209,149 |
| Accumulated Depreciation | $-6,564,508 | $-5,642,649 | $-8,133,108 | $-7,807,559 |
| Gross PPE | $28,418,506 | $28,343,251 | $30,163,148 | $22,016,708 |
| Leases | $1,227,094 | $1,227,094 | $1,262,238 | $1,258,738 |
| Other Properties | $819,626 | $806,339 | $1,033,157 | $606,034 |
| Machinery Furniture Equipment | $6,643,736 | $6,581,768 | $9,940,290 | $8,936,802 |
| Buildings And Improvements | $17,129,171 | $17,129,171 | $11,215,134 | $11,215,134 |
| Land And Improvements | $2,598,879 | $2,598,879 | $0 | $11,215,134 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $2,977,013 | $2,935,183 | $574,183 | $17,620 |
| Investments And Advances | - | $0 | $308,000 | $308,000 |
| Construction In Progress | - | $0 | $6,712,329 | $0 |
| Available For Sale Securities | - | - | $308,000 | $308,000 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-11-30 | 2024-11-30 | 2023-11-30 | 2022-11-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $5,248,131 | $2,407,202 | $1,280,786 | $-8,595,812 |
| Operating Activities | ||||
| Operating Cash Flow | $5,478,606 | $6,010,910 | $8,919,754 | $8,572,647 |
| Cash Flow From Continuing Operating Activities | $5,478,606 | $6,010,910 | $8,919,754 | $8,572,647 |
| Operating Gains Losses | $48,304 | $-105,887 | $-122,113 | $-407,344 |
| Investing Activities | ||||
| Capital Expenditure | $-230,475 | $-3,603,708 | $-7,638,968 | $-17,168,459 |
| Investing Cash Flow | $-975,332 | $-4,876,899 | $-8,144,754 | $-15,279,639 |
| Cash Flow From Continuing Investing Activities | $-975,332 | $-4,876,899 | $-8,144,754 | $-15,279,639 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-169,502 | $-1,423,871 | $-799,036 | $-1,819,915 |
| Financing Cash Flow | $-4,745,203 | $-979,118 | $-2,072,891 | $147,862 |
| Cash Flow From Continuing Financing Activities | $-4,745,203 | $-979,118 | $-2,072,891 | $147,862 |
| Cash Dividends Paid | $-3,231,227 | $-2,020,539 | $0 | $-7,672,728 |
| Common Stock Dividend Paid | $-3,231,227 | $-2,020,539 | $0 | $-7,672,728 |
| Net Common Stock Issuance | $-169,502 | $-1,423,871 | $-799,036 | $-1,819,915 |
| Net Other Financing Charges | - | $228,000 | $-67,500 | $-196,501 |
| Other | ||||
| Repayment Of Debt | $-10,167,575 | $-3,059,110 | $-2,156,355 | $-7,346,996 |
| Issuance Of Debt | $8,800,000 | $5,220,000 | $950,000 | $16,632,728 |
| Interest Paid Supplemental Data | $2,029,012 | $1,976,808 | $1,808,751 | $1,259,884 |
| Income Tax Paid Supplemental Data | $4,594,638 | $2,716,993 | $1,820,802 | $1,572,602 |
| End Cash Position | $319,031 | $560,960 | $406,067 | $1,703,958 |
| Beginning Cash Position | $560,960 | $406,067 | $1,703,958 | $8,263,088 |
| Changes In Cash | $-241,929 | $154,893 | $-1,297,891 | $-6,559,130 |
| Proceeds From Stock Option Exercised | $23,101 | $76,402 | $0 | $551,274 |
| Common Stock Payments | $-169,502 | $-1,423,871 | $-799,036 | $-1,819,915 |
| Net Issuance Payments Of Debt | $-1,367,575 | $2,160,890 | $-1,206,355 | $9,285,732 |
| Net Short Term Debt Issuance | $-1,220,000 | $2,297,272 | $-1,050,000 | $2,272,728 |
| Short Term Debt Payments | $-10,020,000 | $-2,922,728 | $-2,000,000 | $-5,400,000 |
| Short Term Debt Issuance | $8,800,000 | $5,220,000 | $950,000 | $7,672,728 |
| Net Long Term Debt Issuance | $-147,575 | $-136,382 | $-156,355 | $7,013,004 |
| Long Term Debt Payments | $-147,575 | $-136,382 | $-156,355 | $-1,946,996 |
| Net Investment Purchase And Sale | $-859,857 | $-1,273,191 | $-505,786 | $18,820 |
| Sale Of Investment | $2,787,907 | $1,618,232 | $577,137 | $1,161,032 |
| Purchase Of Investment | $-3,647,764 | $-2,891,423 | $-1,082,923 | $-1,142,212 |
| Net Intangibles Purchase And Sale | $0 | $-1,200,000 | $-799,999 | $-5,000,000 |
| Purchase Of Intangibles | $0 | $-1,200,000 | $-799,999 | $-5,000,000 |
| Net PPE Purchase And Sale | $-115,475 | $-2,403,708 | $-6,838,969 | $-10,298,459 |
| Sale Of PPE | $115,000 | $0 | $0 | $1,870,000 |
| Purchase Of PPE | $-230,475 | $-2,403,708 | $-6,838,969 | $-12,168,459 |
| Change In Working Capital | $2,838,438 | $3,698,366 | $5,985,373 | $4,250,405 |
| Change In Other Working Capital | $4,359,432 | $5,454,211 | $5,304,967 | $4,953,476 |
| Change In Other Current Liabilities | $-424,701 | $-245,169 | $-271,232 | $-312,067 |
| Change In Other Current Assets | $-179,387 | $-64,648 | $36,929 | $284,329 |
| Change In Payables And Accrued Expense | $-531,588 | $215,343 | $2,271,070 | $643,951 |
| Change In Accrued Expense | $-1,531,845 | $639,063 | $1,582,135 | $528,424 |
| Change In Payable | $1,000,257 | $-423,720 | $688,935 | $115,527 |
| Change In Account Payable | $1,000,257 | $-423,720 | $688,935 | $115,527 |
| Change In Prepaid Assets | $-35,627 | $-90,790 | $-148,117 | $-88,900 |
| Change In Inventory | $56,190 | $429,178 | $360,445 | $490,002 |
| Change In Receivables | $-405,881 | $-1,999,759 | $-1,568,689 | $-1,720,386 |
| Changes In Account Receivables | $-405,881 | $-1,999,759 | $-1,568,689 | $-1,720,386 |
| Other Non Cash Items | $20,822 | $24,031 | $-1,029,347 | $451,167 |
| Stock Based Compensation | $417,101 | $781,128 | $816,639 | $461,345 |
| Unrealized Gain Loss On Investment Securities | $806,267 | $-1,076,051 | $-50,777 | $38,972 |
| Provisionand Write Offof Assets | $868,795 | $1,266,905 | $1,036,390 | $929,618 |
| Asset Impairment Charge | $4,358,834 | $308,000 | $16,845,197 | $0 |
| Deferred Tax | $-2,818,688 | $-309,274 | $-6,750,350 | $-1,732,266 |
| Deferred Income Tax | $-2,818,688 | $-309,274 | $-6,750,350 | $-1,732,266 |
| Depreciation Amortization Depletion | $1,368,118 | $1,021,597 | $1,710,411 | $1,809,342 |
| Depreciation And Amortization | $1,368,118 | $1,021,597 | $1,710,411 | $1,809,342 |
| Depreciation | $1,368,118 | $1,021,597 | $1,710,411 | $1,809,342 |
| Gain Loss On Sale Of PPE | $48,304 | $0 | $0 | $-407,344 |
| Net Income From Continuing Operations | $-2,429,385 | $402,095 | $-9,521,669 | $2,771,408 |
| Gain Loss On Investment Securities | - | $-105,887 | $-122,113 | $38,972 |
| Long Term Debt Issuance | - | - | $0 | $8,960,000 |
Fetched: 2026-06-14